NanoBusiness Commercialization Association Names Lynn L. Bergeson As One of the Most Influential Nanotechnology Leaders

0

Source: Acta Group

Bergeson & Campbell, P.C. (B&C), B&C Consortia Management, L.L.C. (BCCM), The Acta Group, L.L.C. (Acta), and The Acta Group EU, Ltd (Acta EU) are pleased to announce that the NanoBusiness Commercialization Association (NbCA) has included Lynn L. Bergeson on its 'Most Influential Nanotechnology Leaders List from 2011.' The NbCA is the industry association for the emerging nanotechnology industry. Through its extensive network of leading start-ups, Fortune 500 companies, research institutions, non-governmental organizations, and public-private partnerships, the NbCA shapes nanotechnology policy and helps accelerate the responsible commercialization of nanotechnology innovation. B&C is honored by this recognition, and salutes Vince Caprio for his leadership and commitment to the nano industry.

We urge you to log on to B&C's Nano and Other Emerging Chemical Technologies Blog, which reports regularly on federal, local, and international regulatory, legal, and policy developments involving nanotechnologies and other emerging chemical technologies. The blog is available at nanotech.lawbc.com. Users may sign up to receive e-mails of new posts to the blog online.

About Bergeson & Campbell, P.C. -- Located in Washington, D.C., B&C is a law firm focusing on conventional and nanoscale industrial, agricultural, and specialty chemical product regulation and approval matters, including Toxic Substances Control Act (TSCA) matters, Federal Insecticide, Fungicide and Rodenticide Act (FIFRA)/Food Quality Protection Act (FQPA) matters, U.S. Food and Drug Administration (FDA) medical device and product approval, registration and data compensation arbitrations, chemical product litigation, and associated business counseling and litigation issues. B&C's clients are involved in many businesses, including conventional and nanoscale basic, specialty, and agricultural and antimicrobial chemicals; biotechnology, nanotechnology, and emerging transformative technologies; consumer products; medical devices and diagnostic products; paints and coatings; and plastic products. Additional information is available at www.lawbc.com.

About B&C Consortia Management, L.L.C. -- BCCM, an affiliate of B&C, has strong institutional experience in consortia management. BCCM provides cost effective administrative and management services to consortia to ensure their interests are protected and their voices heard on issues of concern. BCCM works with industry groups to develop or expand advocacy and/or product stewardship programs, to develop and conduct communications outreach to local, state, federal, or international government entities, to formulate and initiate research programs -- whether voluntary or in response to regulatory requirements, and many other activities. Additional information is available at www.bc-cm.com.

About The Acta Group, L.L.C. and The Acta Group EU, Ltd -- Acta and Acta EU are consulting affiliates of B&C, established to control the spiraling costs and inefficiencies encountered by clients seeking approvals to market agricultural and industrial chemicals, products of biotechnology and nanotechnology, and Food and Drug Administration-regulated products. Acta and Acta EU manage products from concept to approval, utilizing the skills and experience of professionals who have worked in the specific product areas in government and industry. Additional information is available at www.actagroup.com.

Customer comments

No comments were found for NanoBusiness Commercialization Association Names Lynn L. Bergeson As One of the Most Influential Nanotechnology Leaders. Be the first to comment!